Description

Meropenem Powder for Solution for Injections 500 mg. Vial №10

Ingredients:

Each vial contains Meropenem (as Meropenem Trihydrate) 500 mg.

Dosage:

The usual dose is 500 mg every 8 hours for most infections. Dosage adjustments may be needed based on the severity of the infection and renal function.

Indications:

Meropenem is indicated for the treatment of various bacterial infections, including intra-abdominal infections, skin and skin structure infections, and bacterial meningitis.

Contraindications:

Do not use Meropenem if there is a known hypersensitivity to any component of the product. Caution is advised in patients with a history of seizures.

Directions:

Meropenem is administered by intravenous infusion over approximately 15 to 30 minutes. It is important to follow the instructions provided by the healthcare provider.

Scientific Evidence:

Meropenem, a broad-spectrum antibiotic, has been extensively studied for its efficacy in treating various bacterial infections. Clinical trials have demonstrated its effectiveness in combating resistant pathogens and its favorable safety profile. Research published in the Journal of Antimicrobial Chemotherapy highlighted the high success rates of Meropenem in severe infections.

Additional Information:

Meropenem exhibits bactericidal activity by inhibiting cell wall synthesis in bacteria. Its broad spectrum of activity makes it a valuable option in the treatment of serious infections. Compared to similar drugs, Meropenem has shown superior efficacy in certain cases, making it a preferred choice for healthcare providers.

Studies have shown that Meropenem is well-tolerated and effective in complicated infections, making it a cornerstone in the management of critically ill patients. Its ability to penetrate tissues and reach high concentrations at the site of infection contributes to its clinical success.